IPSEN (OTCMKTS:IPSEY) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened

IPSEN (OTCMKTS:IPSEY)’s share price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $45.40 and traded as high as $46.6650. IPSEN shares last traded at $46.45, with a volume of 289 shares changing hands.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on IPSEY. Barclays raised shares of IPSEN from a “strong sell” rating to a “hold” rating in a research note on Thursday, September 17th. Jefferies Financial Group downgraded shares of IPSEN from a “hold” rating to a “moderate sell” rating in a research report on Sunday, August 2nd. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold”.

IPSEN Trading Up 0.2%

The business has a 50-day simple moving average of $43.37 and a 200-day simple moving average of $45.43.

About IPSEN

IPSEN is a global biopharmaceutical company headquartered in France. Founded in 1929, it develops and commercializes medicines focused on oncology, rare diseases and neuroscience. Its portfolio includes treatments such as Somatuline for certain neuroendocrine tumors and acromegaly, Dysport for several neurological and aesthetic uses, and Cabometyx for certain cancers. The company also conducts research and development to advance medicines across its therapeutic areas. IPSEN serves patients and healthcare professionals in countries around the world through its international commercial operations and partnerships.